- Acquired by Adicet Bio, Jan 2016
- Raised $4M funding round, Apr 2010
- Raised $400k grant, Jul 2008
About
Applied Immune Technologies (AIT) is a drug development company specializing in T-cell-receptor-like (TCRL) antibodies for therapeutic and diagnostic applications in a variety of cancer, viral, and autoimmune diseases. The company also focuses on the identification and validation of novel therapeutic targets. AIT's core technology platforms encompass the identification and validation of novel MHC-based targets, as well as the development of therapeutic human recombinant TCRL antibodies with the ability to bind with these intracellular peptide/MHC complexes with the specificity of cytotoxic T-cell killer cells. AIT's technologies have the potentialto drive a pipeline of therapeutic TCRL antibodies for intracellularly derived, disease-specific targets that normally are not accessible to conventional antibodies. TCRL antibodies also have diagnostic applications in vaccine design, validation, and monitoring, as well as analysis of antigen presentation in diseases.
Funding history · 2 rounds · $4.4M total
Q&A
- What is Applied Immune Technologies' primary focus?
- Applied Immune Technologies (AIT) is a drug development company specializing in T-cell-receptor-like (TCRL) antibodies for therapeutic and diagnostic applications in various cancer, viral, and autoimmune diseases. The company also focuses on identifying and validating novel therapeutic targets.
- When was Applied Immune Technologies founded?
- Applied Immune Technologies was founded in February 2006.
- What is the current status of Applied Immune Technologies?
- Applied Immune Technologies was acquired by Adicet Bio in January 2016 and is currently inactive.
- How much funding has Applied Immune Technologies raised in total?
- Applied Immune Technologies has raised a total of $4,400,000.
- Which investors participated in Applied Immune Technologies' funding rounds?
- Applied Immune Technologies received funding from the Office of the Chief Scientist and Pontifax.
- What is the employee count for Applied Immune Technologies?
- Applied Immune Technologies has 1-10 employees.
- Who is a founder of Applied Immune Technologies?
- Aya Yakobovitz, Ph.D. is a founder, director, and senior strategic advisor at Applied Immune Technologies.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/6951128 |
Identifiers & details
| Founded | 2006-2 |
|---|---|
| Status reason | Acquired (Inactive) by Adicet Bio on Jan 2016 - closed due to acquisition |
Acquisitions & public offerings
Acquired by Adicet Bio 2016-01
Radar intelligence
Patents
| EPO | 22 |
|---|